Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Minerva Neurosciences - 11 Year Stock Price History | NERV

Historical daily share price chart and data for Minerva Neurosciences since 2014 adjusted for splits and dividends. The latest closing stock price for Minerva Neurosciences as of June 02, 2025 is 1.56.
  • The all-time high Minerva Neurosciences stock closing price was 117.60 on May 26, 2020.
  • The Minerva Neurosciences 52-week high stock price is 3.69, which is 136.5% above the current share price.
  • The Minerva Neurosciences 52-week low stock price is 1.15, which is 26.3% below the current share price.
  • The average Minerva Neurosciences stock price for the last 52 weeks is 2.33.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Minerva Neurosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.8014 2.3000 2.6800 1.3400 1.5600 -29.78%
2024 3.5008 6.1500 12.4700 2.1000 2.2216 -63.88%
2023 5.5195 1.5100 13.0500 1.5100 6.1500 286.79%
2022 5.1200 7.3592 13.4300 1.4300 1.5900 -75.19%
2021 17.6405 19.0400 28.7200 6.4080 6.4080 -65.77%
2020 42.6013 61.1200 117.6000 18.0800 18.7200 -67.09%
2019 52.6430 55.3600 69.2800 32.6400 56.8800 5.49%
2018 64.3960 49.6000 100.4000 40.4000 53.9200 11.40%
2017 62.2709 94.0000 98.8000 39.6000 48.4000 -48.51%
2016 76.6441 47.0400 115.0400 28.3200 94.0000 93.57%
2015 42.9533 48.8800 51.9200 34.7200 48.5600 0.83%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.011B $0.000B
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The Company's pipeline will initially target the treatment of schizophrenia, major depressive disorder (MDD), insomnia, and Parkinson's disease. Its product candidates include MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences, Inc. is based in Cambridge, MA, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.830B 32.20
Zoetis (ZTS) United States $75.075B 28.01
Daiichi Sankyo, - (DSNKY) Japan $50.952B 25.92
Takeda Pharmaceutical (TAK) Japan $47.824B 9.51
Sandoz Group AG (SDZNY) Switzerland $22.282B 0.00
Merck (MKKGY) Germany $17.034B 12.48
United Therapeutics (UTHR) United States $14.382B 12.72
Shionogi (SGIOY) Japan $14.036B 0.00
Summit Therapeutics (SMMT) United States $13.528B 0.00
Neurocrine Biosciences (NBIX) United States $12.175B 41.70
IPSEN (IPSEY) France $9.924B 0.00
Orion OYJ (ORINY) Finland $9.462B 25.59
Corcept Therapeutics (CORT) United States $8.225B 66.86
Stevanato Group S.p.A (STVN) Italy $6.726B 41.13
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.112B 0.00
Grifols, S.A (GRFS) Spain $5.714B 0.00
Ionis Pharmaceuticals (IONS) United States $5.333B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.696B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.045B 10.67
Crinetics Pharmaceuticals (CRNX) United States $2.857B 0.00
Hypermarcas (HYPMY) Brazil $2.812B 18.50
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.294B 12.41
BioCryst Pharmaceuticals (BCRX) United States $2.249B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.033B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.804B 0.00
Indivior (INDV) United States $1.773B 7.52
Recursion Pharmaceuticals (RXRX) United States $1.699B 0.00
ARS Pharmaceuticals (SPRY) United States $1.417B 0.00
Evotec AG (EVO) Germany $1.410B 0.00
Dyne Therapeutics (DYN) United States $1.359B 0.00
Guardian Pharmacy Services (GRDN) United States $1.340B 0.00
Ocular Therapeutix (OCUL) United States $1.276B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.059B 21.19
Harrow (HROW) United States $1.031B 0.00
Collegium Pharmaceutical (COLL) United States $0.936B 5.05
Avadel Pharmaceuticals (AVDL) Ireland $0.881B 0.00
Ardelyx (ARDX) United States $0.878B 0.00
Enliven Therapeutics (ELVN) United States $0.872B 0.00
Akebia Therapeutics (AKBA) United States $0.796B 0.00
Xeris Biopharma Holdings (XERS) United States $0.773B 0.00
Cronos Group (CRON) Canada $0.763B 0.00
AleAnna (ANNA) United States $0.624B 0.00
KalVista Pharmaceuticals (KALV) United States $0.587B 0.00
Elite Pharmaceuticals (ELTP) United States $0.577B 0.00
Xencor (XNCR) United States $0.569B 0.00
USANA Health Sciences (USNA) United States $0.556B 12.09
Regulus Therapeutics (RGLS) United States $0.549B 0.00
Bioventus (BVS) United States $0.532B 13.50
Relay Therapeutics (RLAY) United States $0.514B 0.00
Zevra Therapeutics (ZVRA) United States $0.468B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.459B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.458B 0.00
Altimmune (ALT) United States $0.440B 0.00
Tourmaline Bio (TRML) United States $0.428B 0.00
Siga Technologies (SIGA) United States $0.427B 8.93
Oruka Therapeutics (ORKA) United States $0.410B 0.00
Verve Therapeutics (VERV) United States $0.397B 0.00
Savara (SVRA) United States $0.394B 0.00
Organogenesis (ORGO) United States $0.348B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.343B 9.28
Tonix Pharmaceuticals Holding (TNXP) United States $0.291B 0.00
Heron Therapeutics (HRTX) United States $0.287B 0.00
Nature's Sunshine Products (NATR) United States $0.284B 26.20
Aquestive Therapeutics (AQST) United States $0.269B 0.00
MediWound (MDWD) Israel $0.237B 0.00
ProKidney (PROK) United States $0.212B 0.00
Nanobiotix S.A (NBTX) France $0.193B 0.00
Journey Medical (DERM) United States $0.188B 0.00
Esperion Therapeutics (ESPR) United States $0.168B 0.00
4D Molecular Therapeutics (FDMT) United States $0.168B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Profound Medical (PROF) Canada $0.158B 0.00
Aclaris Therapeutics (ACRS) United States $0.158B 0.00
OmniAb (OABI) United States $0.155B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Avita Medical (RCEL) United States $0.149B 0.00
Wellgistics Health (WGRX) United States $0.144B 0.00
Larimar Therapeutics (LRMR) United States $0.144B 0.00
Liminatus Pharma (LIMN) $0.141B 0.00
Nektar Therapeutics (NKTR) United States $0.135B 0.00
Lyell Immunopharma (LYEL) United States $0.129B 0.00
Aldeyra Therapeutics (ALDX) United States $0.129B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.127B 0.00
Achieve Life Sciences (ACHV) Canada $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.117B 0.00
Korro Bio (KRRO) United States $0.107B 0.00
Cardiol Therapeutics (CRDL) Canada $0.103B 0.00
VAXART, INC (VXRT) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Cassava Sciences (SAVA) United States $0.097B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.093B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Inotiv (NOTV) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
Galectin Therapeutics (GALT) United States $0.083B 0.00
Champions Oncology (CSBR) United States $0.081B 13.34
Pyxis Oncology (PYXS) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 55.11
Surrozen (SRZN) United States $0.073B 0.00
Nutriband (NTRB) United States $0.073B 0.00
Unicycive Therapeutics (UNCY) United States $0.071B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Telomir Pharmaceuticals (TELO) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
NRx Pharmaceuticals (NRXP) United States $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Acrivon Therapeutics (ACRV) United States $0.033B 0.00
FibroGen (FGEN) United States $0.029B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.026B 0.00
Relmada Therapeutics (RLMD) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Tempest Therapeutics (TPST) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.019B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
SHINECO (SISI) China $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00